|
Research
Front Name
|
Percentage of corporate affiliations
|
Leading
corporation
|
|
DRUG DISCOVERY USING HIGH-RESOLUTION LIQUID
CHROMATOGRAPHY/QUADRUPOLE TIME-OF-FLIGHT MASS
SPECTROMETRY
|
45
|
Waters Corp
|
|
ALLOSTERIC AKT (PKB) INHIBITORS; ISOENZYME-SPECIFIC AKT
INHIBITORS; AKT SIGNALING PATHWAY; CANCER CELLS
OVEREXPRESSING AKT
|
37
|
Merck & Co, Inc
|
|
QUANTITATIVE HIGH-PERFORMANCE LIQUID
CHROMATOGRAPHY-ELECTROSPRAY-TANDEM MASS SPECTROMETRY
|
36
|
Merck & Co, Inc
|
|
HEPATITIS C VIRUS SERINE PROTEASE INHIBITOR; HEPATITIS
C VIRUS NS3 PROTEASE; NOVEL HEPATITIS C VIRUS PROTEASE
INHIBITOR
|
28
|
Boehringer Ingelheim
|
|
NONINFLAMMATORY SYNTHETIC SIRNA; POTENT GENE SILENCING
IN-VIVO; SMALL INTERFERING RNA INHIBITS TUMOR GROWTH
|
25
|
Alnylam Pharmaceuticals
|
|
PROTEIN-LIGAND DOCKING; FULLY AUTOMATIC FLEXIBLE
MOLECULAR DOCKING; SIMILARITY-BASED VIRTUAL SCREENING
USING 2D FINGERPRINTS
|
25
|
Astex Technology Ltd
|
|
TYPE 2 DIABETES MELLITUS; TYPE 2 DIABETES FAILING
THIAZOLIDINEDIONE MONOTHERAPY; SUBOPTIMALLY CONTROLLED
TYPE 2 DIABETES
|
25
|
Merck & Co, Inc
|
|
ENANTIOSELECTIVE HYDROGENATION USING HETEROGENEOUS
MODIFIED CATALYSTS; ASYMMETRIC HETEROGENEOUS CATALYSIS;
CHIRAL METAL SURFACES
|
23
|
Solvias AG
|
|
GLYPHOSATE-RESISTANT CROPS; EVOLVED
GLYPHOSATE-RESISTANT WEEDS; HERBICIDE-RESISTANT CROPS;
IMIDAZOLINONE-TOLERANT CROPS
|
20
|
BASF Corp
|
